Aligos Therapeutics ALGS
NASDAQ ALGS
$4.96 -0.07 (-1.39%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026)

Updated

Aligos Therapeutics (ALGS) posted Return on Equity [ROE] of -238.60% for Q2 2026, down 170.64 percentage points from -67.96% a year earlier and down 26.91 percentage points from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Aligos Therapeutics' Return on Equity [ROE] came in at -196.92%, up 218.92 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -56.99 percentage points (FY2020 to FY2025).
  • In prior years, Aligos Therapeutics' Return on Equity [ROE] was -415.84% in FY2024 (-326.36 pp), -89.48% in FY2023 (-22.92 pp), -66.55% in FY2022 (-3.14 pp) and -63.41% in FY2021 (+76.51 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q4 2024.
  • On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of -10.93 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2025, with a gain of 1203.76 percentage points; the weakest was Q4 2024, with a drop of 1122.98 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -211.69% (Q1 2026), -38.59% (Q4 2025) and -99.55% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.32%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 7.21%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.52%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 21.39%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 83.75%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -18.38%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 4.97%
10 Aligos Therapeutics 52.83 Mn -275.57 Mn - -238.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -238.60%
Mar 31, 2026 -211.69%
Dec 31, 2025 -38.59%
Sep 30, 2025 -99.55%
Jun 30, 2025 -67.96%
Mar 31, 2025 -121.78%
Dec 31, 2024 -1,242.35%
Sep 30, 2024 -131.18%
Jun 30, 2024 -119.24%
Mar 31, 2024 -131.14%
Dec 31, 2023 -119.37%
Sep 30, 2023 -131.25%
Jun 30, 2023 -106.56%
Mar 31, 2023 -88.40%
Dec 31, 2022 -85.03%
Sep 30, 2022 -86.39%
Jun 30, 2022 -87.20%
Mar 31, 2022 -80.73%
Dec 31, 2021 -63.89%
Sep 30, 2021 -64.80%
API Access

Aligos Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY